Michael J Duryee

9PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesMedical infection agents (incl. prions)Central nervous systemOccupational epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 16, 2026
Attenuation of Cardiac Dysfunction in the Collagen-Induced Arthritis Mouse Model Mediated by a Reactive Aldehyde Species Inhibitor.

|Nov 26, 2025
Citrullinated and Malondialdehyde-Acetaldehyde-Modified Fibrinogen Activates Macrophages and Promotes Coronary Endothelial Cell Inflammation.

Wenxian Zhou, Hannah J Johnson, Michael J Duryee

|Nov 19, 2024
Citrullinated and malondialdehyde-acetaldehyde-modified fibrinogen activates macrophages and promotes profibrotic responses in human lung fibroblasts.

Nozima Aripova, Michael J Duryee, Wenxian Zhou

|May 10, 2024
In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cells.

Sean N Avedissian, Johid R Malik, Anthony T Podany

|Dec 12, 2023
Combined repetitive inhalant endotoxin and collagen-induced arthritis drive inflammatory lung disease and arthritis severity in a testosterone-dependent manner.

Jill A Poole, Geoffrey M Thiele, Elizabeth Ramler

|Dec 10, 2021
Malondialdehyde-Acetaldehyde Modified (MAA) Proteins Differentially Effect the Inflammatory Response in Macrophage, Endothelial Cells and Animal Models of Cardiovascular Disease.

Michael J Duryee, Dahn L Clemens, Patrick J Opperman

Pageof 2

Frequent Collaborators

6 joint publications

Geoffrey M Thiele

4 joint publications

Jill A Poole

3 joint publications

Ted R Mikuls

2 joint publications

Tate M Johnson